Ipsilateral Breast Cancer
Response to neoadjuvant chemotherapy may eliminate need for breast cancer surgery
Select patients with breast cancer who experience pathologic complete response to neoadjuvant systemic therapy and undergo radiotherapy may be able to forego breast surgery, according to study results published in JAMA Oncology.
Saving Sight: New Developments in Treating Retinal Diseases at Massachusetts General Brigham
This activity is supported by an independent medical education grant Regeneron Pharmaceuticals, Inc.
Tamoxifen reduces ipsilateral recurrence risk for certain patients with DCIS
SAN ANTONIO — Tamoxifen lowered overall and invasive ipsilateral recurrence among women with “good-risk” ductal carcinoma in situ who opted for breast conservation surgery without radiation.
Oncology Innovations - TNBC: Bridging Gaps in Care for the Black Community
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Breast-conserving therapy may be viable option for multiple ipsilateral breast cancer
SAN ANTONIO — Lumpectomy followed by radiation therapy resulted in low rates of local recurrence at 5 years among women with multiple ipsilateral breast cancer, according to phase 2 study results.
Postoperative surveillance MRI may reveal risk for second breast cancer
Background parenchymal enhancement at surveillance breast MRI appeared independently associated with future second breast cancer risk among women with a personal history of breast cancer, according to study results published in Radiology.